1992
DOI: 10.1016/s0040-4039(00)79128-3
|View full text |Cite
|
Sign up to set email alerts
|

Improved protection and esterification of a precursor of the taxotere® and taxol side chains

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2000
2000
2016
2016

Publication Types

Select...
3
3
2

Relationship

0
8

Authors

Journals

citations
Cited by 128 publications
(28 citation statements)
references
References 12 publications
0
28
0
Order By: Relevance
“…Reaction of trans-glycidic ester (2a) with 2-nitroaniline(14) The reaction was carried out in silica gel chromatography column. Stirring of the reaction mixture with the slurry of SiO 2 gave similar result.No nitro ester 15-t or 15-e was obtained.…”
mentioning
confidence: 99%
“…Reaction of trans-glycidic ester (2a) with 2-nitroaniline(14) The reaction was carried out in silica gel chromatography column. Stirring of the reaction mixture with the slurry of SiO 2 gave similar result.No nitro ester 15-t or 15-e was obtained.…”
mentioning
confidence: 99%
“…[327] Docetaxel, a paclitaxel analogue, is accessible in a very similar way. [320,328] The drug was developed by Rhône-Poulenc-Rorer and marketed in 1995 under the name Taxotere .…”
Section: Taxolmentioning
confidence: 99%
“…[324] 5.8 Taxol ® Alain Commerçon of the Rhône-Poulenc-Rorer company used (4S,5R)-2,2-dimethyl-4-phenyl-1,3-oxazolidine-5-carboxylic acid as a building block for the side-chain, and he likewise obtained paclitaxel, although in lower yield. [327] Docetaxel, a paclitaxel analogue, is accessible in a very similar way. [320,328] The drug was developed by Rhône-Poulenc-Rorer and marketed in 1995 under the name Taxotere ® .…”
Section: Partial Synthesismentioning
confidence: 99%